This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe treatment-resistant depression in Scotland but intravenous ketamine has not, though it ...

Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...

Known in past decade as a horse tranquilizer and surgical anesthetic, ketamine is now gaining popularity as a party drug and even a life-coping aid. But while it shows promise in treating depression, ...

DANIELLE Littlewood was just 19 when she tried ketamine for the first time – a drug that would soon turn her world upside ...

RISE Integrated Mental Health in York, Maine, offers ketamine therapy for trauma and depression, attracting patients ...

UK woman has issued a stark drug warning after ketamine addiction left her needing the toilet 'every two seconds' ...

Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...

Ketamine is an anesthetic that has been growing in use as an off-label prescription to treat depression. Individuals can access the drug through telehealth appointments and clinics in person. But ...

Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

Ketamine has been used for decades as an anaesthetic drug, but in the past few years, more and more psychiatrists have been using it for hard-to-treat depression ...

NRx Pharmaceuticals (NASDAQ: NRXP) , a clinical-stage biopharmaceutical company, is executing a dual growth strategy focused on expanding its nationa ...